Delivery Order SPE2DB22D2007-SPE2DB24FJ0KG

Award Date 3/11/24
Potential Completion Date 3/12/24
Potential Value $2.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,298.98 delivery order contract is for the supply of fentanyl 50 mcg/hr patches. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a Firm Fixed Price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $1,037.24. The award is for the supply of Fentanyl 75 MCG/HR Patch 5S, a pharmaceutical product, with a period of performance through April 12, 2024. Amerisourcebergen Drug Corp has an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025,...
This federal contract award, with ID SPE2DX22D0010|SPE2D825FFP04, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,497.41 firm fixed-price delivery order is for the supply of 4,568,199,705 units of Fentanyl Transderm Patch 37.5MCG, a pain management pharmaceutical. This award is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $1,528.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of Fentanyl Transdermal Patches, a critical pharmaceutical product, to support the Department of Defense's (DoD) medical treatment programs and facilities worldwide. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,523.30 firm fixed-price contract is for the delivery of 4567438595 - Fentanyl Transdermal Patches 37.5 MCG. The award has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Fentanyl Transderm Patch 37.5MCG medical supplies. The $2,400.65 firm fixed-price delivery order has an ultimate completion date of October 12, 2023 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $7,044.15, is for the delivery of Fentanyl Transdermal Patches with a 37.5 mcg dosage. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,804.87 firm-fixed-price delivery order is for the supply of 4565884446 Fentanyl Transdermal Patches at 37.5 mcg. The contract has an ultimate completion date of September 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger indefinite delivery contract valued up to $999,999,999 with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Fentanyl Transdermal Patches, 37.5 mcg, with a ceiling value of $1,979.46 and an ultimate completion date of March 27, 2023. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,303.62 firm-fixed price delivery order is for the supply of Fentanyl Transderm Patches, a pain management medication, with a performance period through June 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ0KG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The award, a firm fixed price delivery order valued at $2,930.48, is for the supply of 4563925337 - Fentanyl 75 MCG/HR Patch 5S, a pharmaceutical product.

The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense military treatment programs and facilities worldwide. This IDC was awarded solely to Amerisourcebergen Drug Corp and does not fall under any overarching contract vehicles.

The contract has no set-aside designation and was awarded to Amerisourcebergen Drug Corp as the prime contractor, with its parent company Cencora, Inc. (doing business as Amerisourcebergen) as the parent vendor. The ultimate completion date for this delivery order is March 12, 2024.

Generated 6/10/24, 9:33 AM